Windtree Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Windtree Therapeutics generated cash of -$13,437,000, which is more than the previous year. Cash used in financing activities reached the amount of $11,595,000 last year. Net change in cash is therefore -$1,857,000.
Cash Flow
| 2014 | -41.16M | -780K | 377K |
|---|---|---|---|
| 2015 | -33.50M | -188K | 27.70M |
| 2016 | -33.58M | -254K | 709K |
| 2017 | -21.04M | -24K | 17.29M |
| 2018 | -15.78M | -13.72M | 38.73M |
| 2019 | -24.66M | 13.79M | 21.76M |
| 2020 | -25.31M | -291K | 19.95M |
| 2021 | -23.66M | -279K | 29.36M |
| 2022 | -19.45M | 197K | 3.07M |
| 2023 | -13.43M | -15K | 11.59M |
WINT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.32M | 22.50M | 17.08M | 22.73M | 11.35M | 2.04M | 5.81M | 38.72M | 44.71M | 86.28M |
Operating activities | ||||||||||
Net income | -20.29M | -39.20M | -67.63M | -32.56M | -27.47M | -20.53M | -18.44M | -39.49M | -55.17M | -44.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 82K | 533K | 192K | 165K | 195K | 159K | 192K | 255K | 712K | 818K |
Stock-based compensation expense | 1.27M | 3.08M | 7.23M | 5.68M | 6.72M | 0 | 1.65M | 1.68M | 2.23M | 3.92M |
| Deferred income tax benefit | 1.27M | 3.08M | 7.23M | 5.68M | 6.72M | 0 | 1.65M | 1.68M | 2.23M | 3.92M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.92M | 67K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201K | -1.78M |
Accounts payable | 560K | -444K | -468K | -547K | -2.46M | 997K | 2.43M | 1.44M | 2.91M | -1.08M |
Cash generated by operating activities | -13.43M | -19.45M | -23.66M | -25.31M | -24.66M | -15.78M | -21.04M | -33.58M | -33.50M | -41.16M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -13.95M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -15K | -13K | -279K | -291K | -191K | 0 | -24K | -281K | -458K | -780K |
Acquisitions Net | 0 | 210K | 0 | 0 | 0 | 223K | 0 | 0 | 270K | 0 |
Cash generated by investing activities | -15K | 197K | -279K | -291K | 13.79M | -13.72M | -24K | -254K | -188K | -780K |
Financing activities | ||||||||||
Common Stock Issued | 11.54M | 4.25M | 32.23M | 20.24M | 22.98M | 32.89M | 15.89M | 0 | 136K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -797K | -1.17M | -3.87M | -3.77M | 0 | -1.66M | 3.9M | 0 | 0 | -80K |
Cash used in financing activities | 11.59M | 3.07M | 29.36M | 19.95M | 21.76M | 38.73M | 17.29M | 709K | 27.70M | 377K |
Net Change In Cash | -1.85M | -16.17M | 5.41M | -5.64M | 11.37M | 9.31M | -3.77M | -33.13M | -5.98M | -41.57M |
Cash at end of period | 4.46M | 6.32M | 22.50M | 17.08M | 22.73M | 11.35M | 2.04M | 5.58M | 38.72M | 44.71M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |